Composition
- Active ingredients
- TERBINAFINE HYDROCHLORIDE EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TERBINAFINE HYDROCHLORIDE 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CreamNDA020192-001 · Discontinued
- TERBINAFINE HYDROCHLORIDE 1% · SolutionNDA020749-001 · Discontinued
- TERBINAFINE HYDROCHLORIDE 1% · CreamNDA020980-001 · Over the counter
- TERBINAFINE HYDROCHLORIDE EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- TERBINAFINE HYDROCHLORIDE EQ 187.5MG BASE/PACKET · GranuleNDA022071-002 · Discontinued
- TERBINAFINE HYDROCHLORIDE EQ 125MG BASE/PACKET · GranuleNDA022071-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020539.
At a glance
- Brand name
- Lamisil
- Active substance
- terbinafine hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Novartis
- Status
- Discontinued
- FDA approval
- 10 May 1996
- Application
- NDA020539-001